Urogenital Myiasis

Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist
14 Views
Rx Blood, Metabolism, and Infectious Diseases (A - Z)

Urogenital myiasis (also called genitourinary myiasis) is a rare condition where fly larvae (immature flies) are found in or near the urinary or genital area, such as the vulva, vagina, penis, scrotum, urethral opening, or nearby skin wounds. It usually happens when flies lay eggs on soiled clothing, damp dressings, skin ulcers, or around the genital opening, and the larvae later appear in the genital region or urine. Doctors diagnose myiasis by finding larvae and, when needed, identifying the larvae by their body structures (for example, spiracles and mouthparts) or by expert laboratory identification. Because it is uncommon and symptoms can look like a usual urine or genital infection, careful examination and proper specimen handling are important. PMC+3CDC+3CDC+3

Urogenital myiasis means fly larvae (maggots) infest the urinary or genital area—for example the urethra, bladder, vagina, vulva, or skin around the genitals. It usually happens when a fly lays eggs near an opening, moist skin, soiled clothing, or an untreated wound, and the larvae later enter or stay close to the urogenital area. It is rare, but reported more in tropical/subtropical climates and in people with poor hygiene access, chronic illness (like diabetes), open sores, urinary catheters, incontinence, immobility, or immunosuppression. PMC+3CDC+3ScienceDirect+3

Other names

You may see urogenital myiasis described as genitourinary myiasis, urinary myiasis, urethral myiasis, vulvovaginal myiasis, penile myiasis, or scrotal myiasis. These names simply point to the main place involved (urine/urinary tract, urethra, vulva/vagina, penis, or scrotum). Index Copernicus Journals+3PMC+3ScienceDirect+3

Types

  • Urinary myiasis

  • Urethral myiasis

  • Vulvar myiasis

  • Vaginal (vulvovaginal) myiasis

  • Penile myiasis

  • Scrotal myiasis

  • Superficial urogenital myiasis (mainly skin and surface tissues)

  • Deep urogenital myiasis (deeper tissues or cavities, usually linked to wounds/ulcers) DermNet®+2PMC+2

Urinary myiasis means larvae are noticed in urine or connected with the urinary pathway. It is rare and can be mistaken for urinary infection unless the history and specimen are checked carefully. ScienceDirect+1

Urethral myiasis means the problem is centered around the urethral opening or urethra. Some reports describe egg laying near the urethral exit with later symptoms during urination. turkarchpediatr.org+1

Vulvar and vaginal (vulvovaginal) myiasis involve the external female genital area and/or vagina, often linked with poor hygiene, prolonged dampness, or nearby wounds/ulcers that attract flies. PMC+2ScienceDirect+2

Penile and scrotal myiasis involve the male genital skin, especially when there is an ulcer, chronic skin disease, diabetes, poor hygiene, or an indwelling catheter that increases moisture and contamination risk. Index Copernicus Journals+2PMC+2

Superficial urogenital myiasis mainly affects skin layers or exposed surfaces, often around wounds or dressings. Deep urogenital myiasis is more serious because it involves deeper tissues, usually when there is a neglected wound or severe underlying disease. DermNet®+2MSD Manuals+2

Causes (risk factors and common situations)

  1. Poor personal hygiene
    When the genital area is not cleaned well, smells and secretions can attract flies, increasing the chance of egg laying around the urogenital region. PMC+1

  2. Low socioeconomic conditions or poor living environment
    Limited access to clean toilets, bathing facilities, and clean water can raise exposure to flies and contamination. ScienceDirect+1

  3. Living in warm, tropical, or subtropical climates
    Flies are more active in warm weather, and myiasis is reported more often in warm regions. jcimcr.org+1

  4. Sleeping or staying in fly-infested places
    Crowded shelters, poorly ventilated rooms, or places with open waste can increase close contact with flies. ScienceDirect+1

  5. Soiled or damp underwear/clothing
    Wet or dirty clothing can attract flies to lay eggs near the genital area, especially if clothes are not changed or washed regularly. turkarchpediatr.org+1

  6. Poor menstrual hygiene
    Prolonged use of unclean pads/cloth and retained moisture can attract flies and increase local irritation and infection risk. Lippincott Journals+1

  7. Chronic genital or perineal ulcers
    Open ulcers provide a place where flies may deposit eggs; this is a well-described setting for wound-related myiasis. MSD Manuals+2PMC+2

  8. Infected wounds or foul-smelling discharge
    Bad odor and wound fluid can attract flies strongly, raising the chance of infestation. MSD Manuals+1

  9. Diabetes mellitus (especially poorly controlled)
    Diabetes can increase skin infections and slow wound healing, which may raise risk in chronic ulcers or catheter users. Index Copernicus Journals+1

  10. Immunocompromised state
    Weakened immunity (from illness or medicines) can increase chronic infection and poor healing, making infestation more likely in neglected wounds. PMC+1

  11. Advanced age (elderly)
    Older adults may have reduced self-care ability and chronic wounds, which are commonly noted risk factors in reports. PMC+1

  12. Bedridden state or limited mobility
    If a person cannot bathe or change clothes easily, moisture and contamination can build up and attract flies. ScienceDirect+1

  13. Mental illness or cognitive impairment
    These conditions can reduce hygiene and wound care, increasing risk in environments with flies. Lippincott Journals+1

  14. Alcohol or substance misuse (neglect of self-care)
    Neglect and exposure to unhygienic settings can raise the chance of myiasis in genital wounds. aaem.pl+1

  15. Indwelling urinary catheter
    Catheters can cause leakage, skin irritation, and contamination, and case reports link catheter use with genital myiasis risk. Index Copernicus Journals+1

  16. Urinary incontinence
    Constant wetness and skin breakdown around the genital area can attract flies and increase infection risk. jcimcr.org+1

  17. Genital prolapse (exposed tissue in females)
    Prolapsed tissue can become ulcerated and exposed, and reports describe myiasis in association with ulcerated or prolapsed organs. ScienceDirect+1

  18. Sexually transmitted or chronic genital infections
    Long-standing infections can cause discharge, irritation, and skin breaks that may attract flies and worsen hygiene problems. Lippincott Journals+1

  19. Recent urogenital surgery or unclean dressings
    Open wounds and dressings that are not kept clean/dry can attract flies, similar to other wound myiasis settings. MSD Manuals+1

  20. Contact with animals, livestock, or waste near living areas
    Flies that breed in animal waste or garbage may increase human exposure when sanitation is poor. CDC+1

Symptoms

  1. Seeing “worms” or moving larvae in urine or near the genital area
    This is the most direct clue. People may notice unusual moving particles in urine or at the genital opening. turkarchpediatr.org+1

  2. Burning or pain during urination (dysuria)
    Irritation near the urethral opening or infection can cause burning while passing urine. turkarchpediatr.org+1

  3. Frequent urination
    Inflammation of the urinary tract can make a person feel the need to urinate many times. turkarchpediatr.org+1

  4. Urgency to urinate
    Some patients feel a sudden strong need to urinate, similar to a urinary tract infection, which is why myiasis can be missed at first. ScienceDirect+1

  5. Lower abdominal discomfort
    Irritation or infection in the bladder area may cause mild lower belly pain. ScienceDirect+1

  6. Genital itching (pruritus)
    Larvae and local inflammation can irritate skin and mucosa, causing itching. turkarchpediatr.org+1

  7. Genital swelling or redness
    Local tissue reaction can cause swelling, warmth, and redness, especially around wounds. MSD Manuals+1

  8. Foul smell from the genital area or wound
    Bad odor can occur with infected discharge or wound involvement and may attract flies further. MSD Manuals+1

  9. Unusual discharge (from wound, vagina, or urethral opening)
    Inflammation or infection can produce discharge, sometimes mixed with blood or pus, depending on the site. MSD Manuals+1

  10. Spotting or mild bleeding
    Fragile inflamed tissue or ulcers may bleed easily, especially with rubbing or urination. PMC+1

  11. Pain or tenderness in the genital area
    Skin breakdown, ulcers, or infection can make the area painful to touch or during movement. MSD Manuals+1

  12. Fever
    Fever is not always present, but it can occur if there is a secondary bacterial infection or severe inflammation. CDC+1

  13. General weakness or feeling unwell
    Chronic infection, poor nutrition, or fever can make a person feel tired and unwell. jcimcr.org+1

  14. Pain in the back/side (flank pain)
    If infection spreads upward in the urinary tract, some people may feel pain near the kidneys. ScienceDirect+1

  15. Urinary retention or weak stream
    Swelling, pain, or associated urinary problems can cause difficulty passing urine, and doctors may evaluate bladder function if symptoms suggest blockage. Cleveland Clinic+1

Diagnostic tests

Physical exams

  1. General exam and vital signs (temperature, pulse, blood pressure)
    Doctors check for fever and signs of serious infection or dehydration, because myiasis can sometimes be complicated by bacterial infection. CDC+1

  2. Careful inspection of the external genital and perineal skin
    A good look at the skin can reveal larvae, ulcers, wet dermatitis, or dirty dressings that explain how infestation happened. Clinical Laboratory Science Journal+1

  3. Pelvic exam (for females) when appropriate
    A clinician may check the vulva/vagina to locate the exact site and assess ulcers or discharge, using safe clinical examination steps. PMC+1

  4. Penile and scrotal exam (for males)
    This checks for ulcers, catheter irritation, skin infection, or other local causes that could attract flies. Index Copernicus Journals+1

  5. Wound/ulcer assessment (size, depth, odor, discharge)
    If there is a wound, clinicians assess whether this is mainly a wound-type myiasis and whether urgent cleaning or surgery is needed. MSD Manuals+1

Manual tests

  1. Abdominal palpation for bladder tenderness
    Gentle pressing on the lower abdomen helps assess bladder irritation, which can mimic a urinary infection. ScienceDirect+1

  2. Costovertebral angle (CVA) tenderness test
    Tapping the back near the kidneys helps screen for upper urinary infection that may happen together with urinary symptoms. NCBI+1

  3. Bimanual pelvic examination (selected cases)
    This helps assess uterine/adnexal tenderness or pelvic infection if symptoms suggest deeper gynecologic involvement. Lippincott Journals+1

Lab and pathological tests

  1. Urinalysis (dipstick and microscopy)
    This checks for white blood cells, blood, and signs of infection, which can guide whether antibiotics are also needed. ScienceDirect+1

  2. Urine culture and sensitivity
    If bacteria are present, culture helps choose the right antibiotic, especially when symptoms look like a UTI. ScienceDirect+1

  3. Collection of the larvae for laboratory identification
    Diagnosis is made by finding larvae, and labs can identify genus/species by features like spiracles and mouthparts. CDC+1

  4. Complete blood count (CBC) with differential
    CBC can show infection signs and sometimes eosinophilia; it also helps judge overall health and inflammation. ScienceDirect+1

  5. CRP and/or ESR (inflammation markers)
    These tests do not confirm myiasis, but they help measure inflammation and monitor severe infection. MSD Manuals+1

  6. Renal function tests (serum creatinine, urea)
    If urinary symptoms are significant, kidney function tests help check for complications, dehydration, or severe infection. NCBI+1

  7. Swab culture from ulcer or infected skin (if present)
    When there is a wound, swabs can identify bacteria that may need treatment along with larval removal and wound care. MSD Manuals+1

Electrodiagnostic / functional tests (when symptoms suggest a bladder function problem)

  1. Uroflowmetry
    This measures urine flow rate and can help evaluate weak stream or obstruction-like symptoms that may need separate management. Cleveland Clinic+1

  2. Urodynamic testing (such as cystometry and pelvic floor EMG)
    If a person has retention, incontinence, or suspected nerve/muscle problems, urodynamics can measure bladder pressure and pelvic floor electrical activity. Cleveland Clinic+2NCBI+2

Imaging tests

  1. Ultrasound of kidneys, ureters, and bladder (KUB ultrasound)
    Ultrasound is a safe way to check for retention, stones, blockage, or infection signs when urinary symptoms are strong. ScienceDirect+1

  2. Bladder scan for post-void residual (PVR)
    This checks how much urine remains after urination, which helps assess retention and guides next steps. Cleveland Clinic+1

  3. Cystoscopy (selected cases)
    If doctors suspect deeper urinary tract involvement or another cause (like tumor, fistula, chronic ulcer), cystoscopy may be used to look inside the bladder/urethra. NCBI+1

Non-pharmacological treatments (therapies and other steps)

  1. Immediate larvae removal (trained removal): The most important step is getting every larva out using careful, controlled techniques (often with good lighting and instruments). This quickly reduces pain, odor, bleeding, and ongoing tissue damage. Purpose: stop active infestation. Mechanism: physical elimination of larvae stops feeding and irritation. Clinical Laboratory Science Journal+2CDC+2

  2. Urogenital irrigation (clinician-directed flushing): For suspected urinary/vaginal involvement, clinicians may use sterile irrigation to help wash out larvae and debris, and to reduce local bacterial load. Purpose: clear larvae and secretions. Mechanism: mechanical flushing + dilution of contaminants. SAGE Journals+2Lippincott Journals+2

  3. Cystoscopy or speculum exam for confirmation: If larvae may be inside the bladder/vagina, a doctor may use endoscopic visualization to confirm location and remove larvae safely. Purpose: find hidden larvae. Mechanism: direct visualization prevents missed larvae and complications. SAGE Journals+2PMC+2

  4. Local anesthesia for comfortable removal: Pain control (local anesthetic) can allow gentle, complete removal without panic or sudden movement. Purpose: safer, complete removal. Mechanism: blocks local nerve signals so instruments can be used carefully. Merck Veterinary Manual+1

  5. Debridement of devitalized tissue (when present): If larvae are in necrotic tissue or a wound, clinicians may remove dead tissue so the area can heal and infection risk drops. Purpose: heal faster, lower infection. Mechanism: removing dead tissue reduces bacterial growth and improves oxygenation. Clinical Laboratory Science Journal+1

  6. Clean wound/skin care (gentle, repeated cleansing): Repeated gentle cleaning of the genital/perineal area removes secretions that attract flies and reduces bacteria. Purpose: reduce reinfestation and infection. Mechanism: lowers odor, moisture, and microbial load. CDC+1

  7. Dry-environment strategy: Keeping the area clean and dry is protective because flies prefer moist, soiled sites. Purpose: stop re-exposure. Mechanism: reduces egg-laying attraction and larval survival. CDC+2SAGE Journals+2

  8. Barrier protection (clean underwear, pads, dressings): Clean barriers protect wounds or moist skin from direct fly contact. Purpose: block egg-laying. Mechanism: physical barrier reduces contact with flies and contaminated surfaces. CDC+1

  9. Catheter and incontinence care: If a catheter or incontinence is present, careful hygiene, frequent changes, and skin protection reduce moisture and odor. Purpose: remove a major risk factor. Mechanism: decreases local wetness and contamination that attract flies. SAGE Journals+1

  10. Environmental fly control at home: Use window screens, proper waste disposal, and control of breeding areas (standing water, exposed trash). Purpose: reduce fly numbers. Mechanism: fewer flies = fewer eggs/larvae exposures. CDC+1

  11. Laundry and bedding hygiene: Wash and dry underwear/bedding regularly; avoid leaving damp clothes in bathrooms. Purpose: stop eggs/larvae on fabric. Mechanism: cleaning and drying disrupts fly life cycle. SAGE Journals+1

  12. Safe bathroom sanitation: Regular cleaning of bathrooms, drains, and damp corners matters because some reported urinary myiasis is linked to moist bathroom environments. Purpose: remove breeding sites. Mechanism: reduces insect habitat and contact. SAGE Journals+1

  13. Specimen collection for identification (if possible): Saving a larva (in a clean container) can help lab identification and public health guidance. Purpose: confirm species and risk. Mechanism: identification guides follow-up and prevention. CDC+1

  14. Check for secondary infection (clinical assessment): A clinician checks for fever, cellulitis, foul discharge, or urinary infection. Purpose: detect complications early. Mechanism: early diagnosis reduces severe infection risk. CDC+1

  15. Hydration and urine flow support (doctor-guided): Adequate fluid intake can support urine flow and comfort, especially if urinary irritation exists. Purpose: symptom support. Mechanism: dilution and flow may reduce irritation and help flush debris. SAGE Journals+1

  16. Pain and itch comfort measures (non-drug): Cool compresses, gentle sitz baths (if advised), and avoiding scratching protect skin. Purpose: reduce trauma. Mechanism: less scratching = fewer skin breaks that attract flies. CDC+1

  17. Diabetes and chronic disease control: Better control of diabetes and chronic wounds reduces vulnerability and improves healing. Purpose: reduce recurrence. Mechanism: improved immunity and tissue repair reduce infestation risk. turkjpediatrdis.org+1

  18. Nutrition and general strength support: In case reports, clinicians emphasize good nutrition and cleanliness, especially in immunosuppressed patients. Purpose: support recovery. Mechanism: adequate protein/energy supports immune response and tissue healing. PMC+1

  19. Follow-up re-check (48–72 hours or as advised): Re-checks help ensure no larvae remain and no infection is developing. Purpose: prevent relapse. Mechanism: early detection of missed larvae prevents ongoing damage. Clinical Laboratory Science Journal+1

  20. Public health notification when relevant: In some settings (e.g., screwworm concerns), clinicians may coordinate with public health. Purpose: protect community and livestock. Mechanism: surveillance and control prevent outbreaks. CDC+1

Drug treatments

Important: Most urogenital myiasis care is removal + hygiene. Medicines are chosen for pain, nausea, secondary bacterial UTI/skin infection, or fungal overgrowth, and selection depends on exam and lab tests. Some drugs below may be off-label for myiasis but are commonly referenced in clinical discussions around parasite/secondary infection management. Clinical Laboratory Science Journal+2ScienceDirect+2

  1. Ivermectin (STROMECTOL): Sometimes used as an antiparasitic option in myiasis discussions, but urogenital myiasis still usually needs physical removal. Class: antiparasitic (avermectin). Typical dosing (label-based): single-day weight-based dosing for labeled parasites; a clinician individualizes any off-label plan. Purpose: reduce larval viability. Mechanism: affects parasite nerve/muscle function. Side effects: may include dizziness, GI upset, and other labeled reactions. FDA Access Data+1

  2. Amoxicillin/clavulanate (AUGMENTIN): Used when there is suspected secondary skin/soft tissue infection or mixed flora. Class: penicillin + beta-lactamase inhibitor. Dose/time (label-based): varies by infection type and kidney function. Purpose: treat bacterial infection. Mechanism: blocks bacterial cell-wall synthesis; clavulanate protects amoxicillin from beta-lactamases. Side effects: diarrhea, rash, allergy, and other labeled risks. FDA Access Data+1

  3. Amoxicillin (AMOXIL): Option for susceptible bacterial infections when clavulanate is not needed. Class: aminopenicillin. Dose/time (label-based): depends on infection; clinician adjusts for age/kidney function. Purpose: treat secondary infection. Mechanism: inhibits bacterial cell-wall synthesis. Side effects: allergy, GI upset, rash, and other labeled effects. FDA Access Data+1

  4. Cephalexin (KEFLEX): Common oral antibiotic for uncomplicated skin/soft tissue infection if appropriate. Class: first-generation cephalosporin. Dose/time (label-based): varies by infection severity. Purpose: treat bacterial infection. Mechanism: inhibits bacterial cell-wall synthesis. Side effects: GI upset, rash, allergy, and other labeled warnings. FDA Access Data+1

  5. Ceftriaxone (ROCEPHIN): Often used in clinics/hospitals for more serious infection or when oral meds are not possible. Class: third-generation cephalosporin (injectable). Dose/time (label-based): clinician-directed; depends on diagnosis and renal/hepatic status. Purpose: treat moderate–severe bacterial infection. Mechanism: cell-wall inhibition. Side effects: injection reactions, allergy, diarrhea, and other label risks. FDA Access Data+1

  6. Trimethoprim-sulfamethoxazole (BACTRIM DS): Option for UTIs/skin infections in selected cases when susceptible. Class: antibacterial combo (folate pathway inhibitors). Dose/time (label-based): depends on infection; hydration and monitoring may be needed. Purpose: treat bacterial infection. Mechanism: blocks bacterial folate synthesis in two steps. Side effects: rash (can be severe), GI upset, sun sensitivity, and other labeled warnings. FDA Access Data+1

  7. Ciprofloxacin (CIPRO): Sometimes used for complicated urinary infections when appropriate and safer options are not suitable. Class: fluoroquinolone. Dose/time (label-based): depends on infection type. Purpose: treat urinary/soft tissue infection. Mechanism: blocks bacterial DNA replication enzymes. Side effects: tendon risks and other serious warnings are in the label; must be clinician-directed. FDA Access Data+1

  8. Doxycycline (VIBRAMYCIN/Vibramycin): Used for certain bacterial infections; also sometimes discussed in parasite-related wound contexts, depending on co-infection risk. Class: tetracycline antibiotic. Dose/time (label-based): varies by infection. Purpose: treat bacteria. Mechanism: blocks bacterial protein synthesis. Side effects: GI upset, sun sensitivity, esophageal irritation, and other label warnings. FDA Access Data+1

  9. Clindamycin (CLEOCIN HCl): Used for skin/soft tissue infection and anaerobic coverage when needed. Class: lincosamide antibiotic. Dose/time (label-based): varies by severity. Purpose: treat secondary infection. Mechanism: inhibits bacterial protein synthesis. Side effects: diarrhea and risk of severe colitis are key label concerns. FDA Access Data+1

  10. Metronidazole (FLAGYL tablets): Used when anaerobic bacteria or certain protozoa are suspected, depending on clinical picture. Class: nitroimidazole. Dose/time (label-based): clinician-directed. Purpose: treat anaerobic infection. Mechanism: damages microbial DNA. Side effects: nausea, metallic taste, and other label warnings. FDA Access Data+1

  11. Metronidazole extended-release (750 mg ER): A formulation used for specific labeled indications; sometimes chosen for tolerance or scheduling reasons if metronidazole is needed. Class: nitroimidazole. Dose/time: label-based regimen differs by indication. Purpose/mechanism: same drug action (DNA disruption). Side effects: as labeled for metronidazole products. FDA Access Data+1

  12. Nitrofurantoin (MACROBID): Common choice for uncomplicated cystitis when bacteria are susceptible. Class: urinary antiseptic/antibacterial. Dose/time (label-based): clinician-directed short course for cystitis. Purpose: treat bladder infection. Mechanism: damages bacterial proteins/DNA via reactive intermediates. Side effects: GI upset and rare lung/liver reactions are label concerns. FDA Access Data+1

  13. Nitrofurantoin macrocrystals (MACRODANTIN): Another nitrofurantoin form used for UTIs; choice depends on clinician preference and indication. Class: urinary antibacterial. Dose/time (label-based): depends on product and diagnosis. Purpose/mechanism: similar antibacterial action in urine. Side effects: similar nitrofurantoin warnings. FDA Access Data+1

  14. Phenazopyridine (urinary pain reliever): Symptom-relief medicine that can reduce burning/urgency while antibiotics treat infection. Class: urinary analgesic. Dose/time (label-based): short-term use only. Purpose: reduce urinary pain. Mechanism: local soothing effect on urinary tract lining (not an antibiotic). Side effects: urine color change; other label warnings apply. FDA Access Data+1

  15. Ibuprofen tablets (MOTRIN prescription strengths): Used for pain and inflammation if safe for the patient. Class: NSAID. Dose/time (label-based): clinician-guided; use lowest effective dose. Purpose: pain/fever control. Mechanism: reduces prostaglandin production. Side effects: GI bleeding risk, kidney effects, and cardiovascular warnings exist. FDA Access Data+1

  16. Ibuprofen injection (CALDOLOR): Hospital option when oral meds are not possible. Class: NSAID (IV). Dose/time (label-based): clinician-directed IV dosing. Purpose: pain/fever. Mechanism: prostaglandin reduction. Side effects: similar NSAID risks plus IV-related issues. FDA Access Data+1

  17. Ibuprofen + famotidine (DUEXIS): A combo used when ibuprofen is needed and stomach protection is also desired in some patients. Class: NSAID + H2 blocker. Dose/time (label-based): fixed-dose tablet schedule. Purpose: pain control with GI protection. Mechanism: ibuprofen reduces prostaglandins; famotidine reduces stomach acid. Side effects: NSAID risks still apply. FDA Access Data+1

  18. Acetaminophen IV (OFIRMEV): Hospital option for pain/fever, often when avoiding NSAIDs. Class: analgesic/antipyretic. Dose/time (label-based): weight-based and time-scheduled dosing limits. Purpose: pain/fever control. Mechanism: central pain/temperature modulation (exact mechanism not fully defined). Side effects: liver toxicity risk if total daily dose is exceeded. FDA Access Data+1

  19. Ondansetron (ZOFRAN): Used if nausea/vomiting occurs from infection, stress, or medications. Class: 5-HT3 antagonist antiemetic. Dose/time (label-based): clinician-directed regimen. Purpose: reduce nausea/vomiting. Mechanism: blocks serotonin signaling involved in vomiting reflex. Side effects: headache, constipation, and QT-related warnings are in labeling. FDA Access Data+1

  20. Fluconazole (DIFLUCAN): Used when fungal overgrowth (like candidiasis) is diagnosed, which can coexist in genital irritation settings. Class: triazole antifungal. Dose/time (label-based): depends on fungal condition. Purpose: treat yeast infection. Mechanism: blocks fungal ergosterol synthesis. Side effects: liver enzyme changes, drug interactions, and other label warnings. FDA Access Data+1

Dietary molecular supplements

These are supportive nutrients that may help overall recovery (skin repair, immune function) when diet is poor. Evidence is indirect for myiasis specifically; do not delay removal/medical care. Dosage here is intentionally conservative: follow clinician advice and avoid “megadoses,” especially in teens. PMC+1

  1. Protein / amino acid support (food-first; supplements if needed): Protein helps tissue repair. If appetite is low, a clinician may suggest oral nutrition drinks. Dosage: individualized; focus on regular protein portions. Function: wound and immune building blocks. Mechanism: supplies amino acids for new tissue and immune proteins. PMC+1

  2. Vitamin C: Often used to support collagen formation in healing. Dosage: use only label-directed daily amounts unless a clinician prescribes more. Function: connective tissue support. Mechanism: supports collagen cross-linking and antioxidant protection. PMC+1

  3. Zinc: Low zinc can slow wound healing. Dosage: avoid high-dose long-term use unless prescribed. Function: immune and skin repair. Mechanism: supports enzymes involved in tissue growth and immune signaling. PMC+1

  4. Vitamin D: Helpful when deficiency exists. Dosage: follow clinician guidance based on lab levels. Function: immune balance. Mechanism: influences immune cell function and inflammatory responses. PMC+1

  5. Iron (only if deficient): Iron deficiency can reduce energy and immunity. Dosage: only with clinician confirmation because excess iron can be harmful. Function: oxygen delivery. Mechanism: supports hemoglobin and immune cell activity. PMC+1

  6. Vitamin B12 (only if low intake/deficient): Supports blood and nerve health, especially in restricted diets. Dosage: label-directed or clinician-directed. Function: cell and blood support. Mechanism: supports DNA synthesis in rapidly dividing cells. PMC+1

  7. Folate (only if deficient): Similar to B12, supports cell renewal. Dosage: avoid excessive folic acid without guidance. Function: tissue and blood support. Mechanism: needed for DNA synthesis and repair. PMC+1

  8. Vitamin A (avoid high doses): Important for skin and mucosal barriers, but excess can be toxic. Dosage: do not exceed label amounts without medical advice. Function: barrier repair. Mechanism: supports epithelial cell growth and immune defense. PMC+1

  9. Omega-3 fatty acids (food-first): May support inflammation balance and overall health. Dosage: prefer fish/food sources; supplements only if advised. Function: inflammation modulation. Mechanism: influences eicosanoid pathways and cell membranes. PMC+1

  10. Probiotics (optional): Sometimes considered if antibiotics cause diarrhea, but not a core myiasis therapy. Dosage: product-specific. Function: gut support. Mechanism: supports microbiome balance during/after antibiotics in some people. PMC+1

Drugs for immunity booster / regenerative support

These are not standard for urogenital myiasis itself. They may be considered only when a clinician identifies a separate problem (e.g., severe neutropenia, complex wounds, or immune deficiency). There is no FDA-approved “stem cell drug” for treating myiasis; true stem-cell treatments should only occur in regulated clinical settings. ScienceDirect+1

  1. Filgrastim (NEUPOGEN): Used when neutrophils are dangerously low (for example, during chemotherapy), which can raise infection risk. Dosage: clinician-directed, condition-specific. Function: immune support via neutrophils. Mechanism: stimulates bone marrow to produce neutrophils. FDA Access Data

  2. Pegfilgrastim (NEULASTA/pegfilgrastim): Longer-acting neutrophil support in selected patients. Dosage: clinician-directed. Function: infection-risk reduction in neutropenia settings. Mechanism: long-acting G-CSF effect increases neutrophil production. FDA Access Data

  3. Sargramostim (LEUKINE): Another colony-stimulating factor used in specific marrow/immune situations. Dosage: specialist-directed. Function: immune recovery support. Mechanism: stimulates growth of certain white blood cells. FDA Access Data+1

  4. Palifermin (Kepivance): A growth factor for mucosal injury in specific oncology settings (not for myiasis). Dosage: specialist-directed. Function: mucosal healing support. Mechanism: stimulates epithelial cell growth and repair. FDA Access Data+1

  5. Becaplermin gel (REGRANEX): A topical growth factor used for certain chronic ulcers (not genital myiasis itself), with careful risk–benefit decisions. Dosage: clinician-directed. Function: wound healing support. Mechanism: platelet-derived growth factor activity helps granulation/tissue repair. FDA Access Data+1

  6. Immune globulin (example: GAMUNEX-C): Used for specific immune deficiency conditions (not for myiasis routinely). Dosage: specialist-directed infusion. Function: provides antibodies. Mechanism: passive immunity by supplying pooled IgG. U.S. Food and Drug Administration+2U.S. Food and Drug Administration+2

Surgeries / procedures (what they are and why they are done)

  1. Cystoscopy with extraction: A scope is used to inspect the bladder/urethra and remove larvae or debris. Why: confirms the site and prevents missed larvae. SAGE Journals+1

  2. Vaginal examination under anesthesia (if needed): Used when pain/anxiety or deep involvement makes complete removal difficult. Why: enables safe, complete removal and cleaning. ScienceDirect+1

  3. Surgical debridement: Removal of dead/infected tissue around wounds. Why: decreases infection risk and supports healing when tissue is damaged. Clinical Laboratory Science Journal+1

  4. Abscess drainage: If secondary bacterial infection forms an abscess, drainage may be required. Why: antibiotics alone may not work if pus is trapped. CDC+1

  5. Repair of underlying anatomic problem (selected cases): If a chronic wound, fistula, or prolapse is creating repeated contamination, repair may be considered. Why: removes the long-term trigger for reinfestation and infection. ScienceDirect+1

Preventions

  1. Keep the genital/perineal area clean and dry, especially after urination or bowel movements. CDC

  2. Treat and cover open wounds/ulcers quickly and keep dressings clean. CDC+1

  3. Use clean underwear daily; wash and fully dry clothing/bedding. SAGE Journals+1

  4. Improve bathroom sanitation; clean damp corners and drains. SAGE Journals+1

  5. Reduce flies: screens, safe waste disposal, remove breeding sites. CDC+1

  6. For catheters/incontinence: follow strict hygiene and skin protection routines. SAGE Journals+1

  7. Manage chronic illnesses (e.g., diabetes) and seek care for chronic sores. turkjpediatrdis.org+1

  8. Avoid sitting in wet/soiled clothing for long periods. SAGE Journals+1

  9. In high-risk areas, protect wounds/orifices from flies when outdoors. CDC+1

  10. If larvae are suspected, seek care fast and don’t “wait it out.” CDC+1

When to see doctors

See a doctor urgently (same day) if you notice worms/larvae, foul-smelling discharge, genital swelling, bleeding, fever, increasing pain, burning urination, blood in urine, or if you are immunocompromised or have diabetes. Early removal and evaluation reduces complications and helps prevent reinfestation. CDC+2SAGE Journals+2

What to eat and what to avoid

  1. Eat: protein foods (eggs, fish, chicken, lentils) to support tissue repair. PMC+1

  2. Eat: fruits/vegetables for vitamins and fluids (food-first approach). PMC

  3. Eat: yogurt/fermented foods if tolerated, especially if on antibiotics. Clinical Laboratory Science Journal+1

  4. Eat: enough calories—poor intake slows healing in vulnerable patients. PMC

  5. Drink: safe water/fluids unless a clinician restricts fluids. SAGE Journals

  6. Avoid: alcohol if taking metronidazole; follow clinician instructions (interaction risk). FDA Access Data+1

  7. Avoid: very sugary diets if diabetes is poorly controlled (supports infections and slows healing). turkjpediatrdis.org+1

  8. Avoid: undercooked/unsafe foods if immunosuppressed. PMC

  9. Avoid: unnecessary “mega-dose” supplements without medical advice. PMC

  10. Avoid: dehydration and skipping meals during illness, because it worsens weakness and recovery. PMC+1

 FAQs

  1. Is urogenital myiasis contagious person-to-person? Usually no; it’s mainly from fly exposure to wounds/soiled moist areas, not from casual contact. CDC+1

  2. Does it mean there are larvae “traveling through the whole body”? Typically no. Larvae usually stay in the local area where eggs were laid or entered. CDC

  3. What is the first and most important treatment? Complete removal of larvae plus cleaning and preventing reinfestation. Clinical Laboratory Science Journal+1

  4. Can I treat it at home? If larvae are present, you should get medical care—clinicians can remove them safely and check for complications. Clinical Laboratory Science Journal+1

  5. Why do some people get urinary myiasis from bathrooms? Some reports link it to moist environments and hygiene challenges, which allow certain flies to thrive. SAGE Journals+1

  6. Is it related to poor hygiene only? Hygiene is a major risk factor, but so are diabetes, wounds, catheters, immobility, and immunosuppression. ScienceDirect+2SAGE Journals+2

  7. Do antibiotics kill the larvae? Antibiotics treat bacteria, not larvae. They may be used if there is a secondary infection. Clinical Laboratory Science Journal+1

  8. Does ivermectin always work? It may be discussed as an antiparasitic, but myiasis management still relies on removal and local care; any use should be clinician-directed (often off-label). FDA Access Data+2Osmosis+2

  9. Can it cause a urinary tract infection (UTI)? It can be associated with irritation and secondary infection risk, so clinicians often evaluate urine and symptoms. SAGE Journals+1

  10. What tests might a doctor do? Urine testing, physical exam, and sometimes endoscopy/imaging if deeper involvement is suspected. SAGE Journals+1

  11. Is it dangerous? It can be, especially with tissue-damaging species or delayed care; early treatment reduces risk. CDC+2Clinical Laboratory Science Journal+2

  12. Will it come back after treatment? It can recur if the environment and risk factors are not fixed (flies, wounds, moisture, sanitation). CDC+1

  13. What should I do with the larvae if I see them? If safe, place one in a clean container for identification, but prioritize getting medical care quickly. CDC+1

  14. Are “stem cell drugs” needed? No. There are no standard stem-cell treatments for myiasis; supportive immune/growth-factor drugs are only for special diagnosed conditions. FDA Access Data+2FDA Access Data+2

  15. How can families prevent this best? Clean/dry care, fast wound treatment, fly control, and quick medical evaluation if larvae are suspected. CDC+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 15, 2025.

PDF Documents For This Disease Condition

  1. Rare Diseases and Medical Genetics.[rxharun.com]
  2. i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
  3. the-UK-rare-diseases-framework.[rxharun.com]
  4. National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
  5. History of rare diseases and their genetic.[rxharun.com]
  6. health-care-and-rare-disorders.[rxharun.com]
  7. Rare Disease Registries.[rxharun.com]
  8. autoimmune-Rare-Genetic-Diseases.[rxharun.com]
  9. Rare Genetic Diseases.[rxharun.com]
  10. rare-disease-day.[rxharun.com]
  11. Rare_Disease_Drugs_e.[rxharun.com]
  12. fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
  13. rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
  14. FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
  15. FDA-rare-disease-lists.[rxharun.com]
  16. 30212783fnl_Rare Disease.[rxharun.com]
  17. FDA-rare-disease-list.[rxharun.com]
  18. List of rare disease.[rxharun.com]
  19. Genome Res.-2025-Steyaert-755-68.[rxharun.com]
  20. uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
  21. PIIS2949774424010355.[rxharun.com]
  22. hidden-costs-2016.[rxharun.com]
  23. B156_CONF2-en.[rxharun.com]
  24. IRDiRC_State-of-Play-2018_Final.[rxharun.com]
  25. IRDR_2022Vol11No3_pp96_160.[rxharun.com]
  26. from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
  27. Rare disease fda.[rxharun.com]
  28. England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
  29. SCRDAC 2024 Report.[rxharun.com]
  30. CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
  31. Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
  32. rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
  33. ENG_White paper_A4_Digital_FINAL.[rxharun.com]
  34. UK_Strategy_for_Rare_Diseases.[rxharun.com]
  35. MalaysiaRareDiseaseList.[rxharun.com]
  36. EURORDISCARE_FULLBOOKr.[rxharun.com]
  37. EMHJ_1999_5_6_1104_1113.[rxharun.com]
  38. national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
  39. be-counted-052722-WEB.[rxharun.com]
  40. RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
  41. genomic-analysis-of-rare-disease-brochure.[rxharun.com]
  42. List-of-rare-diseases.[rxharun.com]
  43. RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
  44. rdnumbers.[rxharun.com] .
  45. Rare disease atoz .[rxharun.com]
  46. EmanPublisher_12_5830biosciences-.[rxharun.com]

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK208609/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
  3. https://rarediseases.org/rare-diseases/
  4. https://rarediseases.info.nih.gov/diseases
  5. https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
  6. https://en.wikipedia.org/wiki/List_of_genetic_disorders
  7. https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
  8. https://medlineplus.gov/genetics/condition/
  9. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  10. https://www.fda.gov/patients/rare-diseases-fda
  11. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
  12. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
  13. https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
  14. https://www.ncbi.nlm.nih.gov/mesh?
  15. https://www.rarediseasesinternational.org/working-with-the-who/
  16. https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
  17. https://www.rarediseasesnetwork.org/
  18. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
  19. https://www.raregenomics.org/rare-disease-list
  20. https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
  21. https://bioresource.nihr.ac.uk/rare
  22. https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
  23. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  24. https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
  25. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  26. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
  27. https://wikicure.fandom.com/wiki/Rare_Diseases
  28. https://www.wikidoc.org/index.php/List_of_genetic_disorders
  29. https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
  30. https://www.orpha.net/en/disease/list
  31. https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
  32. https://ojrd.biomedcentral.com/
  33. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
  34. https://bioportal.bioontology.org/ontologies/ORDO
  35. https://www.orpha.net/en/disease/list
  36. https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
  37. https://www.gao.gov/products/gao-25-106774
  38. https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
  39. https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
  40. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  41. https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
  42. https://globalgenes.org/rare-disease-facts/
  43. https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
  44. https://byjus.com/biology/genetic-disorders/
  45. https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
  46. https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
  47. https://www.thegenehome.com/basics-of-genetics/disease-examples
  48. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  49. https://www.pfizerclinicaltrials.com/our-research/rare-diseases
  50. https://clinicaltrials.gov/ct2/results?recrs
  51. https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
  52. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  53. https://www.nibib.nih.gov/
  54. https://www.nei.nih.gov/
  55. https://oxfordtreatment.com/
  56. https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
  57. https://www.nccih.nih.gov/health
  58. https://catalog.ninds.nih.gov/
  59. https://www.aarda.org/diseaselist/
  60. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  61. https://www.nibib.nih.gov/
  62. https://www.nia.nih.gov/health/topics
  63. https://www.nichd.nih.gov/
  64. https://www.nimh.nih.gov/health/topics
  65. https://www.nichd.nih.gov/
  66. https://www.niehs.nih.gov/
  67. https://www.nimhd.nih.gov/
  68. https://www.nhlbi.nih.gov/health-topics
  69. https://obssr.od.nih.gov/.
  70. https://www.nichd.nih.gov/health/topics
  71. https://rarediseases.info.nih.gov/diseases
  72. https://beta.rarediseases.info.nih.gov/diseases
  73. https://orwh.od.nih.gov/

Related Articles

No widgets added. You can disable footer widget area in theme options - footer options

RxHarun
Logo